As the price of medication skyrockets in 2017, investigating large pharmaceutical companies’ behavior is on the forefront of lowering the cost of medicine. With the help of Supreme Court rulings and patent layering, these companies have been able to take advantage of Food and Drug Administration regulations regarding market exclusivity and in turn are able to control drug costs and manufacturing. This control has caused a series of price gouges and has led to people not being able to afford the medication they require. Using government records, lawsuits, investigative reports, scholarly journals, and proxy statements, this study evaluated the current state of patent law to determine how companies are taking advantage of these loopholes for fiscal and financial gain. Profit margins and salary increases were also cross-referenced to find out if executives were awarding themselves with copious salary increases while raising the cost of life-saving medication.
Dewey, Taryn. 2018. "Overpriced and Under Regulated: A Crackdown on Pharmaceutical Monopolization and Malfeasance." Missouri S&T’s Peer to Peer 2, (1). https://scholarsmine.mst.edu/peer2peer/vol2/iss1/3